What FDA-Approved GLP-1 Medications Exist in 2026 Seven distinct molecules, several brand names: Semaglutide Ozempic (diabetes injection), Wegovy (weight-loss injection and oral), Rybelsus (diabetes oral) Tirzepatide Mounjaro (diabetes injection), Zepbound (weight-loss injection and OSA) Liraglutide Victoza (diabetes injection, daily), Saxenda (weight-loss injection, daily) Dulaglutide Trulicity (diabetes injection, weekly) Exenatide Byetta, Bydureon (diabetes injection) See our complete GLP-1 drug guide for detail on each
Commercially available therapeutic lapidated GLP-1 analogues, semaglutide and liraglutide, have the significant advantage of prolonged in vivo half-lives (hours to days) compared to native GLP-1, which degrades within minutes
Research studies have demonstrated reductions in body weight gain and increased lipolytic activity in adipose tissue
2 Zebrafish models for uncovering therapeutic mechanisms of phytochemicals in metabolic dysfunction-associated steatotic liver disease Metabolic dysfunction-associated steatotic liver disease (MASLD), formerly termed non-alcoholic fatty liver disease (NAFLD), has emerged as a prevalent global health burden, affecting approximately 30% of the adult population (Rinella and Sookoian, 2024)
As a manufacturer of hand sanitizers, the firm is required to test for ethanol content and impurities like methanol
Sultan reviews liver and kidney function with regular lab testing and makes medication or lifestyle adjustments as needed
